Medical and Pharmaceutical bioAffinity Technologies soars Monday as non-invasive lung cancer tech gains traction Shares rose by 73% during the session with no immediate catalyst Rowan DunneMarch 23, 2026
Medical and Pharmaceutical Bacterial infection breath test demonstrates efficacy in rodent studies It can provide results within 10 minutes Rowan DunneMarch 18, 2026
Medical and Pharmaceutical Guardant Health launches multi-cancer blood test in Asia through Manulife partnership Cancer remains a leading cause of death across Asia, driving demand for early screening tools Joseph MortonMarch 18, 2026
Medical and Pharmaceutical Monash University’s medical engineering institute progresses silicosis breath test Its MedTech Commercialisation Advancement Program has been expediting the tool's development Rowan DunneMarch 9, 2026
Medical and Pharmaceutical Optellum breaks new ground with TGA approval for AI-powered lung nodule solution 'Radiological computer-assisted diagnostic software for lesions suspicious of cancer' is what the FDA calls it Rowan DunneMarch 5, 2026
Medical and Pharmaceutical Minnesota’s Vocxi Health and Forj Medical report success with lung cancer breath test It uses nanosensors and AI algorithms to detect volatile organic compounds linked to the disease Rowan DunneMarch 3, 2026
Medical and Pharmaceutical Tempus AI builds on FDA win with Median partnership for lung cancer detection Median secured FDA 510(k) approval for eyonis LCS on Feb. 9 Rowan DunneFebruary 23, 2026
Medical and Pharmaceutical Breath Diagnostics advances pre-op pneumonia screening with FDA breakthrough designation The FDA grants Breakthrough Device status to a limited group of technologies Joseph MortonFebruary 19, 2026
Medical and Pharmaceutical Chinese researchers reveal optical sensor for early lung cancer detection The group combined DNA nanostructures, quantum dots and CRISPR gene-editing tools with a light-based technique called second harmonic generation Joseph MortonFebruary 17, 2026
Medical and Pharmaceutical BillionToOne adds pharmacogenomics, clonal filtering to Northstar cancer test Northstar Select already identifies genetic mutations in advanced solid tumors through a blood sample Joseph MortonFebruary 12, 2026